Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It has been used for decades to treat these conditions, but like all medications, there is a risk of overdose. In this article, we will discuss the dangers of clonidine overdose, how to recognize the signs and symptoms, and how to avoid it.
Clonidine is a prescription medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It is usually taken as a pill, but can also be taken as a patch or liquid.
Clonidine overdose can be dangerous and even fatal. Signs and symptoms of a clonidine overdose may include: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression. In severe cases, an overdose can lead to coma and death.
It is important to be aware of the signs and symptoms of a clonidine overdose. If you or someone you know is taking clonidine and is exhibiting any of the following symptoms, seek medical attention immediately: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
The best way to avoid a clonidine overdose is to take the medication as prescribed by your doctor. Do not take more than the recommended dose and do not take it more often than prescribed.
Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. While it is effective in treating these conditions, there is a risk of overdose. The dangers of clonidine overdose include confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
1.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
2.
Improved end-of-life conversations for cancer patients are identified by a new study.
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
More pain, more gain? New biopsy technique found to improve prostate cancer detection
5.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
1.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
2.
Understanding Melanoma: From Diagnosis to Healing and Excision in Denver
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025
5.
PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
Navigating the Complexities of Ph Negative ALL - Part X
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation